Top Markets
Coin of the day
Coeptis Therapeutics Holdings, Inc. Coeptis Therapeutics Holdings, Inc.

Coeptis Therapeutics Holdings, Inc.

COEP
Clasificación en acciones #28024
Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates... Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates as a biopharmaceutical and technology company. The company is developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its therapeutic portfolio includes an allogeneic cellular immunotherapy platform; and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. The company’s product pipeline consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; CD38-Diagnostic, an in vitro screening tool to analyze cancer patients if cancer patients might be appropriate candidates for anti-CD38 mAb therapy; and SNAP-CAR, a chimeric antigen receptor (CAR) therapy for treatment for cancer. In addition, the company offers its drugs for acute myeloid leukemia and acute respiratory diseases. Coeptis Therapeutics Holdings, Inc. has co-development agreement Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson’s Disease. The company was founded in 2017 and is headquartered in Wexford, Pennsylvania.
Precio por acción
$4.81
Última sincronización: 2026-07-27
Capitalización bursátil
$29.01M
Cambio (1 día)
-8.56%
Cambio (1 año)
-64.66%
País
US
Comercio Coeptis Therapeutics Holdings, Inc. (COEP)

Categoría

Historial del precio de la acción de Coeptis Therapeutics Holdings, Inc. (COEP)
Precio más alto de cierre: $6.93 el 2026-07-01

Precio más bajo de cierre: $201.89 el 2020-12-01
Historial del precio de la acción de Coeptis Therapeutics Holdings, Inc. desde 2020 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -14.55%
2025 310.00%
2024 -80.37%
2023 -39.69%
2022 -84.27%
2021 -1.07%
2020 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$123.19 -13.26%
AU
$753.28 5.84%
CH